VBWG
Meeting report

VBWG Special Report: Second International Conference On Cell Therapy for Cardiovascular Diseases

IN THIS ISSUE:
  • Autologous Cell Therapy in Myocardial Ischemia

  • Cell Therapy as a Surgical Adjuvant

  • Developments in Cardiac Progenitor Cell Research

  • Meeting Highlights



cell_therapy_report.pdf (1.2MB)cell_therapy_report.pdf (1.2MB)

CHARISMA

Download VBWG06_CHARISMA.ppt (13 slides - 0.7MB)

CHARISMA CHARISMA: Background and hypothesis CHARISMA: Study design CHARISMA: Baseline characteristics CHARISMA: Baseline characteristics, cont’d CHARISMA: Concomitant medications CHARISMA: Treatment effect on primary end point CHARISMA: Treatment effect on principal secondary end point CHARISMA: Safety end points CHARISMA: Treatment effect by inclusion criteria CHARISMA: Safety end points by inclusion criteria CHARISMA: Summary CHARISMA: Summary, cont’d


AutologouscardiovascularIschemiaMyocardialSpecialVBWG

Related at vwbg.org

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

Core Curriculum

Contemporary Management of Myocardial Ischemia

View/Download individual slides (119 Slides)

Core Curriculum

Impact of vascular biology on cardiovascular disease, risk prevention, and treatment Section IV - Update: RAAS manipulation and cardiovascular risk--Hope for Peace?

The VBWG Core Curriculum 2004: Impact of vascular biology on cardiovascular disease, risk prevention, and treatment.
More related